Medical Device Technology Alert. Annuloplasty Ring to Treat Mitral Regurgitation; Novel Leadless Artificial Cardiac Pacemaker; 3D Printed Medical Devices on the Rise

USD 950

* Required Fields

USD 950

PAY BY INVOICE

Be the first to review this product

This issue profiles using an annuloplasty ring to treat mitral regurgitation, a novel leadless artificial cardiac pacemaker, and 3D printed medical devices that are on the rise.

Table of Contents

Medical Device Technology Alert. Annuloplasty Ring to Treat Mitral Regurgitation; Novel Leadless Artificial Cardiac Pacemaker; 3D Printed Medical Devices on the RiseIn This Issue1. ANNULOPLASTY RING TO TREAT MITRAL REGURGITATION2. NOVEL LEADLESS ARTIFICIAL CARDIAC PACEMAKER3. NANOPARTICLE APPROACH TO CANCER DRUG DELIVERY4. MEDICAL TRICORDERS--FROM SCIENCE FICTION TO REALITY5. 3D PRINTED MEDICAL DEVICES ON THE RISE6. ELECTRONIC STENTS--THE NEXT GAME-CHANGERS IN INTERVENTIONAL CARDIOLOGY7. INGESTIBLE X-RAY SYSTEMS8. LASER DEVICE FOR CHRONIC PAIN MANAGEMENT




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 31-Oct-17

Region : Global

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Related Subscription

• One-2-One Analyst briefing call •
• Access to published and new research deliverables •
• Mid year service review •
• Virtual Analyst briefing •
• GIL conference seats •

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.